Conversion of Fibroblast into Functional Leydig-like Cell Using Defined Small Molecules

Yan Yang,Chenxing Zhou,Tiantian Zhang,Quan Li,Jiaxin Mei,Jinlian Liang,Ziyi Li,Hanhao Li,Qi Xiang,Qihao Zhang,Lei Zhang,Yadong Huang

DOI: https://doi.org/10.1016/j.stemcr.2020.07.002

2020-01-01

Stem Cell Reports

Abstract:Recent studies have demonstrated that fibroblasts can be directly converted into functional Leydig cells by transcription factors. However, the transgenic approach used in these studies raises safety concerns for its future application. Here, we report that fibroblasts can be directly reprogrammed into Leydig-like cells by exposure to a combination of forskolin, 20α-hydroxycholesterol, luteinizing hormone, and SB431542. These chemical compound-induced Leydig-like cells (CiLCs) express steroidogenic genes and have a global gene expression profile similar to that of progenitor Leydig cells, although not identical. In addition, these cells can survive in testis and produce testosterone in a circadian rhythm. This induction strategy is applicable to reprogramming human periodontal ligament fibroblasts toward Leydig-like cells. These findings demonstrated fibroblasts can be directly converted into Leydig-like cells by pure chemical compounds. This strategy overcomes the limitations of conventional transgenic-based reprogramming and provides a simple, effective approach for Leydig cell-based therapy while simultaneously preserving the hypothalamic-pituitary-gonadal axis.